Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedSep 17, 2025
DataAggregated Company Financials
Companies6
  • 7D1.4%
  • 3M6.3%
  • 1Y-2.5%
  • YTD1.4%

The Pharma industry is up 1.4% in the last week, with Duopharma Biotech Berhad up 2.2%. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 17 Sep 2025RM 4.2bRM 2.8bRM 223.3m16.1x18.9x1.5x
Fri, 15 Aug 2025RM 4.2bRM 2.8bRM 231.0m15.5x18x1.5x
Sun, 13 Jul 2025RM 4.1bRM 2.8bRM 230.3m15.8x17.8x1.5x
Tue, 10 Jun 2025RM 4.1bRM 2.8bRM 230.3m16x17.7x1.4x
Thu, 08 May 2025RM 3.9bRM 2.8bRM 221.0m17.2x17.8x1.4x
Sat, 05 Apr 2025RM 3.8bRM 2.8bRM 221.0m16x17.1x1.4x
Mon, 03 Mar 2025RM 3.9bRM 2.8bRM 221.0m16.6x17.8x1.4x
Wed, 29 Jan 2025RM 4.1bRM 2.7bRM 223.9m16.6x18.2x1.5x
Fri, 27 Dec 2024RM 4.2bRM 2.7bRM 223.9m17.2x18.7x1.5x
Sun, 24 Nov 2024RM 4.2bRM 2.7bRM 234.3m14.3x17.9x1.5x
Tue, 22 Oct 2024RM 4.5bRM 2.7bRM 230.0m14.2x19.4x1.7x
Thu, 19 Sep 2024RM 4.3bRM 2.7bRM 230.0m14.6x18.8x1.6x
Sat, 17 Aug 2024RM 4.3bRM 2.7bRM 545.6m12.5x7.9x1.6x
Mon, 15 Jul 2024RM 4.5bRM 2.6bRM 541.3m13x8.3x1.7x
Wed, 12 Jun 2024RM 4.6bRM 2.6bRM 541.3m13.1x8.4x1.7x
Fri, 10 May 2024RM 4.9bRM 2.6bRM 559.3m12.5x8.7x1.9x
Sun, 07 Apr 2024RM 4.5bRM 2.6bRM 559.3m12.3x8.1x1.7x
Tue, 05 Mar 2024RM 4.5bRM 2.6bRM 559.3m12.5x8.1x1.7x
Thu, 01 Feb 2024RM 4.5bRM 2.6bRM 584.9m12.2x7.7x1.8x
Sat, 30 Dec 2023RM 4.3bRM 2.6bRM 584.9m12.4x7.3x1.7x
Mon, 27 Nov 2023RM 4.2bRM 2.6bRM 591.7m12.3x7.1x1.6x
Wed, 25 Oct 2023RM 4.2bRM 2.6bRM 604.4m12.1x7x1.6x
Fri, 22 Sep 2023RM 4.3bRM 2.6bRM 604.4m12.7x7.1x1.7x
Sun, 20 Aug 2023RM 4.4bRM 2.6bRM 304.2m14.2x14.5x1.7x
Tue, 18 Jul 2023RM 4.4bRM 2.6bRM 304.7m14.6x14.4x1.7x
Thu, 15 Jun 2023RM 4.4bRM 2.6bRM 304.7m14.4x14.4x1.7x
Sat, 13 May 2023RM 4.6bRM 2.5bRM 289.8m13.4x16x1.9x
Mon, 10 Apr 2023RM 4.8bRM 2.5bRM 289.8m13.3x16.6x1.9x
Wed, 08 Mar 2023RM 4.8bRM 2.5bRM 289.8m13.9x16.5x1.9x
Fri, 03 Feb 2023RM 4.6bRM 2.4bRM 270.7m13.4x17.1x1.9x
Sun, 01 Jan 2023RM 4.8bRM 2.4bRM 270.7m13.3x17.6x1.9x
Tue, 29 Nov 2022RM 4.3bRM 2.4bRM 268.1m12.4x16.1x1.8x
Thu, 27 Oct 2022RM 4.0bRM 2.4bRM 249.0m11.7x16x1.7x
Sat, 24 Sep 2022RM 3.9bRM 2.4bRM 249.0m11.7x15.6x1.6x
Price to Earnings Ratio

15.6x


Total Market Cap: RM 3.9bTotal Earnings: RM 249.0mTotal Revenue: RM 2.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 14x202320242025
Current Industry PE
  • Investors are optimistic on the Malaysian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 18.9x which is higher than its 3-year average PE of 14.0x.
  • The industry is trading close to its 3-year average PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 3.6% per year over the last three years.
  • Meanwhile revenues for these companies have grown 5.5% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Malaysian Healthcare industry?

MY Market0.63%
Healthcare1.67%
Pharma1.37%
Pharma1.37%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DPHARMA Duopharma Biotech BerhadRM 1.382.2%
+RM 28.9m
11.3%PE17.3x
AHEALTH Apex Healthcare BerhadRM 2.441.2%
+RM 21.6m
-10.3%PE25.8x
PLABS PeterLabs Holdings BerhadRM 0.283.8%
+RM 2.8m
48.6%PE50.9x
RHONEMA Rhone Ma Holdings BerhadRM 0.671.5%
+RM 2.2m
-5.0%PE11.1x

Latest News